Evolution of experimental models in the study of glioblastoma: toward finding efficient treatments

R Gómez-Oliva, S Domínguez-García… - Frontiers in …, 2021 - frontiersin.org
Glioblastoma (GBM) is the most common form of brain tumor characterized by its resistance
to conventional therapies, including temozolomide, the most widely used chemotherapeutic …

In vitro glioblastoma models: A journey into the third dimension

M Paolillo, S Comincini, S Schinelli - Cancers, 2021 - mdpi.com
Simple Summary In this review, the thorny issue of glioblastoma models is addressed, with a
focus on 3D in vitro models. In the first part of the manuscript, glioblastoma features and …

[HTML][HTML] In vitro biomimetic models for glioblastoma-a promising tool for drug response studies

T Stanković, T Ranđelović, M Dragoj, SS Burić… - Drug Resistance …, 2021 - Elsevier
The poor response of glioblastoma to current treatment protocols is a consequence of its
intrinsic drug resistance. Resistance to chemotherapy is primarily associated with …

Glioblastoma's next top model: novel culture systems for brain cancer radiotherapy research

S Caragher, AJ Chalmers, N Gomez-Roman - Cancers, 2019 - mdpi.com
Glioblastoma (GBM), the most common and aggressive primary brain tumor in adults,
remains one of the least treatable cancers. Current standard of care—combining surgical …

A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxia

A Musah-Eroje, S Watson - Journal of Neuro-oncology, 2019 - Springer
Purpose Glioblastoma (GBM) is the most common invasive malignant brain tumour in adults.
It is traditionally investigated in vitro by culturing cells as a monolayer (2D culture) or as …

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

S Pozzi, A Scomparin, SI Dangoor, DR Ajamil… - Advanced Drug Delivery …, 2021 - Elsevier
The complexity and diversity of the biochemical processes that occur during tumorigenesis
and metastasis are frequently over-simplified in the traditional in vitro cell cultures. Two …

Addressing patient specificity in the engineering of tumor models

LJ Bray, DW Hutmacher, N Bock - Frontiers in Bioengineering and …, 2019 - frontiersin.org
Cancer treatment is challenged by the heterogeneous nature of cancer, where prognosis
depends on tumor type and disease stage, as well as previous treatments. Optimal patient …

Glioblastoma, from disease understanding towards optimal cell-based invitro models

C Boccellato, M Rehm - Cellular Oncology, 2022 - Springer
Background Glioblastoma (GBM) patients are notoriously difficult to treat and ultimately all
succumb to disease. This unfortunate scenario motivates research into better characterizing …

In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview

Z Li, SA Langhans - Frontiers in oncology, 2021 - frontiersin.org
After leukemia, tumors of the brain and spine are the second most common form of cancer in
children. Despite advances in treatment, brain tumors remain a leading cause of death in …

Alginate microfibers as therapeutic delivery scaffolds and tissue mimics

Y Xie, SCR Kollampally… - … Biology and Medicine, 2022 - journals.sagepub.com
Alginate, a naturally occurring polysaccharide, has been widely used in cell encapsulation,
3D culture, cell therapy, tissue engineering, and regenerative medicine. Alginate's frequent …